{"id":"https://openalex.org/W4416635611","doi":"https://doi.org/10.1183/13993003.congress-2025.pa5086","title":"Circulating urokinase-type plasminogen activator receptor (uPAR) associates with progression of idiopathic pulmonary fibrosis (IPF)","display_name":"Circulating urokinase-type plasminogen activator receptor (uPAR) associates with progression of idiopathic pulmonary fibrosis (IPF)","publication_year":2025,"publication_date":"2025-09-27","ids":{"openalex":"https://openalex.org/W4416635611","doi":"https://doi.org/10.1183/13993003.congress-2025.pa5086"},"language":"en","primary_location":{"id":"doi:10.1183/13993003.congress-2025.pa5086","doi":"https://doi.org/10.1183/13993003.congress-2025.pa5086","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa5086","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Idiopathic interstitial pneumonias","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043961879","display_name":"Jamie L. Todd","orcid":"https://orcid.org/0000-0003-4247-3693","observed_orcids":["https://orcid.org/0000-0003-4247-3693"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jamie L. Todd","raw_affiliation_strings":["1Duke Clinical Research Institute and Duke University Medical Centre, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke Clinical Research Institute and Duke University Medical Centre, Durham, NC, United States","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050113875","display_name":"Hillary Mulder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hillary Mulder","raw_affiliation_strings":["2Duke Clinical Research Institute, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Duke Clinical Research Institute, Durham, NC, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033011383","display_name":"Megan Lee Neely","orcid":"https://orcid.org/0000-0002-0101-1081","observed_orcids":["https://orcid.org/0000-0002-0101-1081"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan L Neely","raw_affiliation_strings":["1Duke Clinical Research Institute and Duke University Medical Centre, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke Clinical Research Institute and Duke University Medical Centre, Durham, NC, United States","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024144269","display_name":"Peitao Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peitao Wu","raw_affiliation_strings":["3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019397106","display_name":"John A. Belperio","orcid":"https://orcid.org/0000-0003-2379-5486","observed_orcids":["https://orcid.org/0000-0003-2379-5486"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John A Belperio","raw_affiliation_strings":["4David Geffen School of Medicine at UCLA, Los Angeles, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4David Geffen School of Medicine at UCLA, Los Angeles, California, United States","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058325633","display_name":"Toby M. Maher","orcid":"https://orcid.org/0000-0001-7192-9149","observed_orcids":["https://orcid.org/0000-0001-7192-9149"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Toby M Maher","raw_affiliation_strings":["5Keck School of Medicine, University of Southern California, Los Angeles, California, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Keck School of Medicine, University of Southern California, Los Angeles, California, United States","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009091055","display_name":"Justin M. Oldham","orcid":"https://orcid.org/0000-0003-4957-8869","observed_orcids":["https://orcid.org/0000-0003-4957-8869"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin M Oldham","raw_affiliation_strings":["6Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, United States","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085761603","display_name":"Scott M. Palmer","orcid":"https://orcid.org/0000-0002-1370-3771","observed_orcids":["https://orcid.org/0000-0002-1370-3771"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott M Palmer","raw_affiliation_strings":["1Duke Clinical Research Institute and Duke University Medical Centre, Durham, NC, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Duke Clinical Research Institute and Duke University Medical Centre, Durham, NC, United States","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298","https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091760207","display_name":"Divya C. Patel","orcid":"https://orcid.org/0000-0001-5405-8409","observed_orcids":["https://orcid.org/0000-0001-5405-8409"]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Divya C Patel","raw_affiliation_strings":["3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, United States","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059230424","display_name":"Christian He\u00dflinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Hesslinger","raw_affiliation_strings":["7Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031173643","display_name":"Thomas Schlange","orcid":"https://orcid.org/0000-0002-2027-3976","observed_orcids":["https://orcid.org/0000-0002-2027-3976"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Schlange","raw_affiliation_strings":["7Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"PA5086","last_page":"PA5086"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":0.9629999995231628},{"id":"https://openalex.org/keywords/urokinase-type-plasminogen-activator-receptor","display_name":"urokinase-type plasminogen activator receptor","score":0.9480000138282776},{"id":"https://openalex.org/keywords/circulating-biomarkers","display_name":"circulating biomarkers","score":0.7749999761581421},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.9980000257492065},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.8560000061988831},{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":0.9850000143051147},{"id":"https://openalex.org/keywords/pirfenidone","display_name":"pirfenidone","score":1.0},{"id":"https://openalex.org/keywords/fvc-decline","display_name":"forced vital capacity decline","score":0.7580000162124634},{"id":"https://openalex.org/keywords/risk-indicators","display_name":"risk indicators","score":0.5},{"id":"https://openalex.org/keywords/extracellular-matrix-remodeling","display_name":"extracellular matrix remodeling","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C56219504","wikidata":"https://www.wikidata.org/wiki/Q7900869","display_name":"Urokinase receptor","level":3,"score":0.9160000085830688},{"id":"https://openalex.org/C2776929539","wikidata":"https://www.wikidata.org/wiki/Q7630321","display_name":"SuPAR","level":4,"score":0.8658999800682068},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7545999884605408},{"id":"https://openalex.org/C16020263","wikidata":"https://www.wikidata.org/wiki/Q1778553","display_name":"DLCO","level":5,"score":0.6915000081062317},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.5813999772071838},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.5712000131607056},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5602999925613403},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.5461000204086304},{"id":"https://openalex.org/C2777543607","wikidata":"https://www.wikidata.org/wiki/Q1153419","display_name":"Interstitial lung disease","level":3,"score":0.3878999948501587},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.385699987411499},{"id":"https://openalex.org/C2780675426","wikidata":"https://www.wikidata.org/wiki/Q410485","display_name":"Plasminogen activator inhibitor-1","level":3,"score":0.38100001215934753},{"id":"https://openalex.org/C55520419","wikidata":"https://www.wikidata.org/wiki/Q660995","display_name":"Vital capacity","level":5,"score":0.37389999628067017},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.367900013923645},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.35179999470710754},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.3416999876499176},{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.3384999930858612},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.33719998598098755},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.33399999141693115},{"id":"https://openalex.org/C2776892390","wikidata":"https://www.wikidata.org/wiki/Q7119591","display_name":"Urokinase","level":2,"score":0.3301999866962433},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.329800009727478},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.30809998512268066},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.30239999294281006},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2750999927520752},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.26600000262260437},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26600000262260437},{"id":"https://openalex.org/C75603125","wikidata":"https://www.wikidata.org/wiki/Q1877462","display_name":"Pulmonary function testing","level":2,"score":0.25780001282691956},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.2540999948978424}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1183/13993003.congress-2025.pa5086","doi":"https://doi.org/10.1183/13993003.congress-2025.pa5086","is_oa":false,"landing_page_url":"https://doi.org/10.1183/13993003.congress-2025.pa5086","pdf_url":null,"source":{"id":"https://openalex.org/S4210207896","display_name":"European Respiratory Journal","issn_l":"0903-1936","issn":["0903-1936","1399-3003"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317833","host_organization_name":"European Respiratory Society","host_organization_lineage":["https://openalex.org/P4310317833"],"host_organization_lineage_names":["European Respiratory Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Idiopathic interstitial pneumonias","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2585751935","https://openalex.org/W4367607936","https://openalex.org/W2105297562","https://openalex.org/W2133258083","https://openalex.org/W2552236799","https://openalex.org/W2034903627","https://openalex.org/W2059332421","https://openalex.org/W3031262993","https://openalex.org/W4315649380","https://openalex.org/W953268917"],"abstract_inverted_index":{"Introduction:":[0],"Urokinase":[1],"plasminogen":[2],"activator":[3],"and":[4,15,39,81,108,122,141,172,180,188],"uPAR":[5,26,38,55,80,140,195,233],"form":[6],"an":[7,235],"extracellular":[8],"protease":[9],"cascade":[10],"that":[11],"promotes":[12],"matrix":[13],"remodeling":[14],"growth":[16],"factor":[17],"activation.":[18],"In":[19],"IPF,":[20,243],"lung":[21,94],"fibroblasts":[22],"overexpress":[23],"uPAR.":[24],"Circulating":[25,232],"correlates":[27],"with":[28,53,109,113,193,227],"measures":[29],"of":[30,147,200,219],"IPF":[31,40],"severity.":[32],"Aim:":[33],"Examine":[34],"the":[35,47,77,137],"association":[36,78],"between":[37,79,139],"progression.":[41],"Methods:":[42],"The":[43,152],"cohort,":[44],"drawn":[45],"from":[46],"IPF-PRO":[48],"Registry,":[49],"included":[50,133],"624":[51],"patients":[52,246],"IPF.":[54],"was":[56,132,154,163,223],"quantified":[57],"in":[58,88,242],"plasma":[59],"taken":[60],"at":[61,106,127],"enrollment":[62],"by":[63],"immunoassay":[64],"(Myriad":[65],"RBM).":[66],"Data":[67],"were":[68,73,97,176],"log2":[69,208],"transformed.":[70],"Cox":[71],"models":[72],"used":[74],"to":[75,134],"test":[76],"disease":[82,142,201,240],"progression":[83,143,202,241],"defined":[84],"as":[85],"\u226510%":[86],"decline":[87],"FVC":[89,116,169],"%":[90,117,120,170,174],"predicted,":[91,118,121],"death,":[92],"or":[93],"transplant.":[95],"Models":[96],"adjusted":[98],"for":[99,239],"age,":[100],"sex,":[101],"smoking":[102],"status,":[103],"oxygen":[104,111],"use":[105,112,125],"rest":[107],"activity,":[110],"activity":[114],"only,":[115],"DLCO":[119,173],"antifibrotic":[123,148,228,248],"drug":[124,149,229],"(yes/no)":[126],"enrollment.":[128],"An":[129],"interaction":[130,226],"term":[131],"understand":[135],"whether":[136],"relationship":[138],"differed":[144],"across":[145],"strata":[146],"use.":[150,230],"Results:":[151],"cohort":[153],"74.4%":[155],"male.":[156],"At":[157],"enrollment,":[158],"median":[159,168,217],"(Q1,":[160],"Q3)":[161],"age":[162],"70":[164],"(65,":[165],"75)":[166],"years;":[167],"predicted":[171,175],"69.1":[177],"(58.4,":[178],"79.4)":[179],"43.2":[181],"(33.4,":[182],"51.9),":[183],"respectively;":[184],"25.8%":[185],"took":[186,190],"nintedanib":[187],"23.6%":[189],"pirfenidone.":[191],"Patients":[192],"higher":[194,198,207],"had":[196],"a":[197,216],"risk":[199,237],"(adjusted":[203],"HR":[204],"per":[205],"unit":[206],"concentration:":[209],"1.56":[210],"[95%":[211],"CI":[212],"1.24-1.96];":[213],"p<0.001)":[214],"over":[215],"follow-up":[218],"37":[220],"months.":[221],"There":[222],"no":[224],"significant":[225],"Conclusions:":[231],"is":[234],"independent":[236],"marker":[238],"including":[244],"among":[245],"on":[247],"therapy.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2025-11-25T00:00:00"}